Publication: 2091

Multi-Trial Evaluation of Progression-Free Survival (PFS) as a Surrogate Endpoint for Overall Survival (OS) in First-Line Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
      QxMD      Google Scholar   
Citation:
J Thorac Oncol vol 10 (7) 1099-106
Year:
2015
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Meta-Analysis
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
Yes
Book Volume:
4
Parents:
542   577   964  
Children:
None
Program:
OGC
Primary Committee:
Respiratory
Sec. Committees:
   
Pharmas:
 
Grants:
CA33601, U10 CA031946, U10 CA033601, U10 CA180821, U10 CA066636, U10 CA180882, CA25224, U10 CA023318, P01 CA142538, U10 CA180794, U10 CA180867, U10 CA025224, U10 CA180888, U10 CA180819, CA31946  
Corr. Author:
 
Authors:
                               
Networks:
LAPS-IL057, LAPS-MN026, LAPS-NC010   
Study
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-30103, NCCTG-N0424, NCCTG-932053
Phases:
2
Keywords:
Article